KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Assets (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.87%
Dec 31, 2025 0.05%
Sep 30, 2025 -2.39%
Jun 30, 2025 0.75%
Mar 31, 2025 0.74%
Dec 31, 2024 -5.76%
Sep 30, 2024 1.05%
Jun 30, 2024 -4.66%
Mar 31, 2024 10.51%
Dec 31, 2023 -1.11%
Sep 30, 2023 0.63%
Jun 30, 2023 0.61%
Mar 31, 2023 -3.07%
Dec 31, 2022 -1.78%
Sep 30, 2022 -1.30%
Jun 30, 2022 -0.02%
Mar 31, 2022 -2.26%
Dec 31, 2021 -1.56%
Sep 30, 2021 0.60%
Jun 30, 2021 -1.68%
Mar 31, 2021 -0.04%
Dec 31, 2020 0.63%
Sep 30, 2020 0.06%
Jun 30, 2020 63.96%
Mar 31, 2020 2.34%
Dec 31, 2019 49.92%
Sep 30, 2019 4.02%
Jun 30, 2019 0.66%
Mar 31, 2019 -4.35%
Dec 31, 2018 -10.30%
Sep 30, 2018 7.34%
Jun 30, 2018 -11.11%
Mar 31, 2018 -2.04%
Dec 31, 2017 2.83%
Sep 30, 2017 2.76%
Jun 30, 2017 2.03%
Mar 31, 2017 -0.66%
Dec 31, 2016 -0.79%
Sep 30, 2016 -0.87%
Jun 30, 2016 25.11%
Mar 31, 2016 1.26%
Dec 31, 2015 -3.25%
Sep 30, 2015 1.81%
Jun 30, 2015 101.71%
Mar 31, 2015 -2.96%
Dec 31, 2014 -3.31%
Sep 30, 2014 -2.03%
Jun 30, 2014 1.35%
Mar 31, 2014 -1.85%
Dec 31, 2013 3.35%
Sep 30, 2013 1.23%
Jun 30, 2013 2.73%
Mar 31, 2013 0.60%